FBInvestor
Funds / A16z Capital Management, L.L.C.
Institutional Fund

A16z Capital Management, L.L.C.

Menlo Park, CACIK 15403585 filings on record

Portfolio Value
$1.29B
Q1 2026
Holdings
16
Reported positions
New Buys
4
Opened this quarter
QoQ Change
-18.3%
from $1.58B

Portfolio Value Trend

Reported 13F value by quarter

Portfolio value trend — upgrade to see history

Upgrade

Top Allocations

Largest positions by weight

  • Navan Inc28.9%
  • Figma Inc26.2%
  • Meta Platforms Inc9.4%
  • Revolution Medicines Inc6.9%
  • Nautilus Biotechnology Inc5.3%
  • Block Inc4.7%
  • Other18.4%

Portfolio Holdings

16 positions · Q1 2026

#SecuritySharesValue% Port.Δ SharesActivity
1Navan Inc28.22M$373.62M28.9%+1.02MAdded
2Figma Inc16.01M$338.48M26.2%234.8KReduced
3Meta Platforms Inc212.5K$121.60M9.4%0Held
4Revolution Medicines Inc921.1K$89.58M6.9%0Held
5Nautilus Biotechnology Inc17.65M$68.50M5.3%0Held
6Block Inc1.02M$61.18M4.7%0Held
7Bioage Labs Inc3.23M$56.55M4.4%0Held
8Maze Therapeutics Inc1.70M$50.81M3.9%0Held
9Erasca Inc2.86M$46.32M3.6%0Held
10Galecto Inc1.24M$32.02M2.5%+1.24MNew

6 more holdings on Premium

See this fund's complete portfolio, full position changes, and activity history.

Unlock full portfolio